Skip to main content

Clinical Challenges

With opioid overdose deaths and stimulant use on the rise, FDA director Janet Woodcock highlighted for Rx Summit attendees several of the administration’s top initiatives to meet the challenge.
Marijuana users between the ages of 12 and 17 were found to be twice as likely to develop a substance use disorder vs. those who initiated use between the ages of 18 and 25, according to data in a study conducted by National Institutes of Health (NIH) researchers that was released on Monday.
Overdose deaths among the Latino populations in California and the U.S. as a whole have sharply increased in recent years, “a canary in the coal mine” for groups that have traditionally seen fewer overdose deaths than the national average for the general population, according to the Drug Policy Alliance.
Individuals with opioid use disorder have turned to easily accessible medications containing loperamide to ease withdrawal symptoms or replace opioids. Providers should watch for signs and symptoms of misuse.
Lucy Cannon, EdD, LCSW, LICSW, CCDP-D, MATS, discusses what’s causing a rise in stimulant use among African Americans and how providers can create a more inclusive environment for treatment.
In this video, Robert Rymowicz, DO, of the Rutgers New Jersey Medical School, discusses food addiction, how highly processed foods affect the brain, and treatment strategies.
Back to Top